IFC to make $47.5 mn debt investment in Granules India

February 20, 2017 | TEAM VCC

International Finance Corporation, the private-sector arm of the World Bank, is planning to provide $47.5 million (Rs 318 crore) in debt funding to drugmaker Granules India Ltd.

The corporate loan will help the company execute its expansion programme, IFC said in a disclosure note.

Eris Lifesciences files DRHP for IPO; ChrysCap to exit

February 10, 2017 | Ranjani Raghavan

Ahmedabad-based pharmaceutical firm Eris Lifesciences Pvt. Ltd filed a draft red herring prospectus with the capital markets regulator Securities and Exchange Board of India (SEBI) for an initial public offering (IPO) on Wednesday.

Aurobindo Pharma buys four biosimilar drugs from TL Biopharmaceutical

February 10, 2017 | Joseph Rai

Drugmaker Aurobindo Pharma Ltd has bought four biosimilar products from Swiss firm TL Biopharmaceutical AG, marking its entry into the evolving biosimilar space, a company statement said.

Exclusive: Creador-backed Corona Remedies set to buy a clutch of drugs

February 08, 2017 | Ranjani Raghavan

Less than a year after it raised capital from private equity firm Creador Capital, Gujarat-based drugmaker Corona Remedies Pvt. Ltd is engaged in advanced talks to buy a portfolio of drugs from a multi-national pharmaceuticals company to scale up its business, VCCircle has learnt.

Cipla scouts for more acquisitions to build US biz

February 08, 2017 | Reuters

Indian drugmaker Cipla Ltd's third-quarter profit beat estimates due to higher sales in the United States, and the company said it was looking for licensing deals and acquisitions to build its speciality medicines pipeline in that market.

Strides Shasun, SeQuent Scientific to merge bulk drugs units

February 03, 2017 | Joseph Rai & Ranjani Raghavan

Strides Shasun Ltd and SeQuent Scientific Ltd have agreed to merge some of their bulk drugs businesses and separately sell a few others to sharpen their focus, the two drugmakers said on Friday.

Exclusive: ChrysCapital logs partial exit from PIPE portfolio with handsome returns

February 02, 2017 | Joseph Rai

ChrysCapital Investment Advisors India Pvt Ltd, which is in the process of raising its new fund, has offloaded more stake in a fairly young portfolio firm as it seeks to harvest returns in the public listed space.

Cheer for medical devices, pharma; industry largely disappointed

February 01, 2017 | Joseph Rai

Finance Minister Arun Jaitley on Wednesday significantly raised the budget allocation for healthcare expenditure for FY2017-18 while offering reasons to cheer for the medical devices and pharmaceuticals sector. However, the industry at large has been disappointed by the Union Budget.

Piramal to acquire drugs from UK firm Mallinckrodt for $171 mn

January 30, 2017 | Joseph Rai

Billionaire Ajay Piramal-led Piramal Enterprises Ltd said on Monday it will acquire a portfolio of drugs from UK-based Mallinckrodt LLC for $171 million (Rs 1,163 crore) in its seventh pharmaceutical deal within two years.

Zydus Cadila acquires US drugmaker Sentynl Therapeutics

January 20, 2017 | Joseph Rai

Cadila Healthcare Ltd, which operates under the brand Zydus Cadila, has purchased US-based specialty pharmaceuticals company Sentynl Therapeutics Inc for an undisclosed amount in its second acquisition within three weeks.



Upcoming Events